Document Type: RESEARCH PAPER

Authors

1 Cellular and Molecular Research Center & Department of Anatomical Sciences, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

2 Department of Community Medicine, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

3 Department of Anatomical Sciences, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

4 Department of Pathology, University of Washington, Seattle, Washington, USA

Abstract

Background: Repair of bone defects is challenging for reconstructive and orthopedic surgeons. In this study, we aimed
to histomorphometrically assess new bone formation in tibial bone defects filled with octacalcium phosphate (OCP),
bone matrix gelatin (BMG), and a combination of both.
Methods: A total of 96 male Sprague Dawley rats aged 6-8 weeks weighing 120-150 g were randomly allocated
into three experimental (OCP, BMG, and OCP/BMG) and one control group (n=24 in each group). The defects in
experimental groups were filled with OCP (6 mg), BMG (6 mg), or a combination of OCP and BMG (6 mg, 2:1 ratio).
No material was used to fill the defects in the control group and the defect was only covered with Surgicel. Samples
were taken on days 7, 14, 21, and 56 after the surgery. The sections were stained with hematoxylin-eosin (H&E) and
assessed using light microscopy.
Results: In our experimental groups, bone formation was started from the margins of the defect towards the center
with an increasing rate during the study period. Moreover, the formed bone was more mature. Bone formation in our
control group was only limited to the margins of the defect. The newly formed bone mass was significantly higher in
the experimental groups (P=0.001).
Conclusion: OCP, BMG, and OCP/BMG compound enhanced osteoinduction in long bones.
Level of evidence: III

Keywords

Main Subjects

1. Bauer TW, Muschler GF. Bone graft materials: an
overview of the basic sciences. Clin Orthop Relat Res.
2000; 371(1):10-27.
2. Finkemeier CG. Bone-grafting and bone-graft
substitutes. J Bone Joint Surg Am. 2002; 48(3):454-64.
3. Bayat M, Momen-Heravi F, Marjani M, Motahhary
P. A comparison of bone reconstruction following
application of bone matrix gelatin and autogenous
bone grafts to alveolar defects: an animal study. J
Craniomaxillofac Surg. 2010; 38(4):288-92.
4. Arvidson K, Abdallah B, Applegate LA, Baldini N,
Cenni E, Gomez‐Barrena E, et al. Bone regeneration
and stem cells. J Cell Mol Med. 2011; 15(4):718-46.
5. Garcí􀆴a-Gareta E, Coathup MJ, Blunn GW.
Osteoinduction of bone grafting materials for bone
repair and regeneration. Bone. 2015; 81(1):112-21.
6. Amina AR, Laurencin CT, Nukavarapu SP. Bone tissue
engineering: recent advances and challenges. Crit Rev
Biomed Eng. 2012; 40(5):363-408.
7. Wang L, Detamore MS. Tissue engineering the
mandibular condyle. Tissue Eng. 2007; 13(8):1955-71.
8. Raghoebar GM, Meijndert L, Kalk WW, Vissink
A. Morbidity of mandibular bone harvesting: a
comparative study. Int J Oral Maxillofac Implants.
2007; 22(3):356-65.
9. Ghanaati S, Barbeck M, Orth C, Willershausen I, Thimm
BW, Hoffmann C, et al. Influence of β-tricalcium
phosphate granule size and morphology on tissue
reaction in vivo. Acta Biomater. 2010; 6(12):4476-87.
10. Gruskin E, Doll BA, Futrell FW, Schmitz JP, Hollinger
JO. Demineralized bone matrix in bone repair: history
and use. Adv Drug Deliv Rev. 2012; 64(12):1063-77.
11. Canter HI, Vargel I, Mavili ME. Reconstruction of
mandibular defects using autografts combined with
demineralized bone matrix and cancellous allograft.
J Craniofac Surg. 2007; 18(1):95-100.
12. Liu X, Ma PX. Polymeric scaffolds for bone tissue
engineering. Ann Biomed Eng. 2004; 32(3):477-86.
13. Bayat M, Momen Heravi F, Mahmoudi M, Bahrami N.
Bone reconstruction following application of bone
matrix gelatin to alveolar defects: a randomized
clinical trial. Int J Organ Transplant Med. 2015;
6(4):176-81.
14. Murakami Y, Honda Y, Anada T, Shimauchi H, Suzuki O.
Comparative study on bone regeneration by synthetic
octacalcium phosphate with various granule sizes.
Acta Biomater. 2010; 6(4):1542-8.
15. Suzuki O, Nakamura M, Miyasaka Y, Kagayama M,
SakuraiM. Bone formation on synthetic precursors
of hydroxyapatite. Tohoku J Exp Med. 1991;
164(1):37-50.
16. Kikawa T, Kashimoto O, Imaizumi H, Kokubun S,
Suzuki O. Intramembranous bone tissue response to
biodegradable octacalcium phosphate implant. Acta
Biomater. 2009; 5(5):1756-66.
17. Kamakura S, Sasano Y, Shimizu T, Hatori K, Suzuki 

O, Kagayama M, et al. Implanted octacalcium
phosphate is more resorbable than ß-tricalcium
phosphate and hydroxyapatite. J Biomed Mater Res.
2002; 59(1):29-34.

18. Sargolzaei Avval FS, Arab H, Sarani SA, Saberi EA.
Implantation of octacalcium phosphate enhances
alveolar ridge in rat mandible. J Dent Sch. 2008;
25(2):167-73.
19. Sargolzaei-Aval F, Sobhani A, Arab MR, Sarani SA,
Heydari MH. The efficacy of implant of octacalcium
phosphate in combination with bone matrix gelatin
on bone regeneration in skull defects in rat. Iran J Med
Sci. 2004; 29(3):124-9.
20. Lyon T, Scheele W, Bhandari M, Oval KJ, Sanchez EG,
Christensen J, et al. Efficacy and safety of recombinant
human bone morphogenetic protein-2/calcium
phosphate matrix for closed tibia diaphysis fracture:
a double-blind, randomized, controlled phase-II/III
trial. J Bone Joint Surg Am. 2013; 95(23):2088-96.
21. Lee FY, Storer S, Hazan EJ, Gebhardt MC, Mankin
HJ. Repair of bone allograft fracture using bone
morphogenetic protein-2. Clin Orthop Relat Res.
2002; 397(1):119-26.
22. Yan WQ, Oka M, Nakamura T. Bone bonding in
bioactive glass ceramics combined with bone matrix
gelatin. J Biomed Mater Res. 1998; 42(2):258-65.
23. Urist MR, Iwata H, Ceccotti PL, Dorfman RL, Boyd SD,
McDowell RM, et al. Bone morphogenesis in implants
of insoluble bone gelatin. Proc Natl Acade Sci. 1973;
70(12):3511-5.
24. Pan Y, Dong S, Hao Y, Chu T, Li C, Zhang Z, et al.
Demineralized bone matrix gelatin as scaffold
for tissue engineering. Afr J Microbiol Res. 2010;
4(9):865-70.
25. Liu Y, Ahmad S, Shu XZ, Sanders RK, Kopesec SA,
Prestwich GD. Accelerated repair of cortical bone
defects using a synthetic extracellular matrix to
deliver human demineralized bone matrix. J Orthop
Res. 2006; 24(7):1454-62.
26. Ö􀇆 ztürk A, Yetkin H, Memis L, Cila E, Bolukbasi
S, Gemalmaz C. Demineralized bone matrix and
hydroxyapatite/tri-calcium phosphate mixture for
bone healing in rats. Int Orthop. 2006; 30(3):147-52.
27. Anada T, Kumagai T, Honda Y, Masuda T, Kamijo R,
Kamakura S, et al. Dose-dependent osteogenic effect
of octacalcium phosphate on mouse bone marrow
stromal cells. Tissue Eng Part A. 2008; 14(6):965-78.
28. Suzuki O. Octacalcium phosphate: osteoconductivity
and crystal chemistry. Acta Biomater. 2010;
6(9):3379-87.
29. Kim J, Lee KW, Ahn JH, Kim JY, Lee TY, Choi
B. Osteoinductivity depends on the ratio of
demineralized bone matrix to acellular dermal matrix
in defects in rat skulls. Tissue Eng Regen Med. 2013;
10(5):246-51.
30. Sobhani A, Sargolzaei F, Akbari M, Rafighdoust H,

Abbasi M, Kashani IR. Repair of cranial bone defects
using endochondral bone matrix gelatin in rat. Acta
Med Iran. 2001; 39(1):24-30.

31. Legeros RZ. Preparation of octacalcium phosphate
(OCP): a direct fast method. Calcif Tissue Int. 1985;
37(2):194-7.
32. Suzuki O, Nakaura M, Miyasaka Y, Kagayama M,
Sakurai M. Maclurapomifera agglutinin-binding
glycoconjugates on converted apatite from synthetic
octacalcium phosphate implanted into subperiosteal
region of mouse calvarial. Bone Miner. 1993;
20(2):151-66.
33. Suzuki O, Yagishita H, Amano T, Aoba T. Reversible
structural changes of octacalcium phosphate and labile
acid phosphate. J Dent Res. 1995; 74(11):1764-9.
34. Kim JH, Kim HW. Rat defect models for bone grafts
and tissue engineered bone constructs. Tissue Eng
Regen Med. 2013; 10(6):310-6.
35. Kamakura S, Sasano Y, Homma H, Suzuki O, Kagayama
M, Motegi K. Implantation of octacalcium phosphate
(OCP) in rat skull defects enhances bone repair. J Dent
Res. 1999; 78(11):1682-7.
36. Parifitt AM. Bone histomorphometry: techniques and
interpretation. Florida: CRC Press; 1983.
37. Mulliken JB, Glowaki J. Induced osteogenesis for
repair and construction in the craniofacial regions.
Plast Reconstr Surg. 1980; 65(5):535-60.
38. Suzuki O, Imaizumi H, Kamakura S, Katagiri T. Bone
regeneration by synthetic octacalcium phosphate and
its role in biological mineralization. Curr Med Chem.
2008; 15(3):305-13.
39. Shafieian R, Moghaddam Matin M, Rahpeyma A, Fazel
A, Salari Sedigh H, Sadr Nabavi A, et al. Effects of
human adipose-derived stem cells and platelet-rich
plasma on healing response of canine alveolar surgical
bone defects. Arch Bone Jt Surg. 2017; 5(6):406-418.
40. Holt DJ, Grainger DW. Demineralized bone matrix as
a vehicle for delivering endogenous and exogenous
therapeutics in bone repair. Adv Drug Deliv Rev. 2012;
64(12):1123-8.
41. Wang Z, Zhang J, Zhang Q, Gao Y, Yan J, Zhao X, et al.
Evaluation of bone matrix gelatin/fibrin glue and
chitosan/gelatin composite scaffolds for cartilage
tissue engineering. Genet Mol Res. 2016; 15(3):1-8.